Investor Relations

Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.

Upcoming Events

Wounds Canada National Hybrid Conference

Oct 17 – Oct 19, 2024

View All Events

Stock Information

Company Overview

Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.

Corporate Presentation

Corporate Presentation

Download Corporate Presentation

Leadership

Having accumulated decades of collective experience across a variety of fields, our leadership team is the source of our success.

Investor Contact Information

Company

Kane Biotech Inc.
290-100 Innovation Drive
Winnipeg, MB R3T 6G2
Canada
T: (204) 453-1301
ir@kanebiotech.com

Investor Relations

Kane Biotech Inc.
Nicole Sendey
Investor Relations & Public Relations
T: 204-453-1301
nsendey@kanebiotech.com

Transfer Agent

Canadian Stock Transfer Company Inc.
600, 333 – 7th Avenue S.W.
Calgary, Alberta T2P 2Z1